» Articles » PMID: 35967579

Do Not Forget Asthma Comorbidities in Pediatric Severe Asthma!

Overview
Journal Front Pediatr
Specialty Pediatrics
Date 2022 Aug 15
PMID 35967579
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma is the most common chronic respiratory disease in childhood. The long-term goals in managing asthma aim to control symptoms and prevent exacerbations, as well as to reduce side effects of therapy and mortality disease-related. Most of patients have mild to moderate asthma and respond well to standard therapies. However, a minor proportion of children with asthma has severe disease that remains uncontrolled despite optimal adherence to prescribed therapy and treatment of contributory factors, including trigger exposures and comorbidities, which can mimic or worsen asthma and contribute to exacerbations and poor quality of life. Evaluation of comorbidities is fundamental to optimize the management of the disease in a subgroup of patients with poor responder asthma. The overall aim of this article is to describe characteristics of main pediatric severe asthma comorbidities reported in literature, giving clinicians tools to recognize and manage properly these conditions.

Citing Articles

Beneficial effects of pleuran on asthma control and respiratory tract-infection frequency in children with perennial asthma.

Jesenak M, Hrubisko M, Chudek J, Bystron J, Rennerova Z, Diamant Z Sci Rep. 2025; 15(1):7146.

PMID: 40021713 PMC: 11871075. DOI: 10.1038/s41598-025-91830-2.


Progress in diagnosis and treatment of difficult-to-treat asthma in children.

Zhou X, Zhang P, Tan H, Dong B, Jing Z, Wu H Ther Adv Respir Dis. 2023; 17:17534666231213637.

PMID: 38069568 PMC: 10710755. DOI: 10.1177/17534666231213637.

References
1.
Sacco O, Silvestri M, Ghezzi M, Capizzi A, Rossi G . Airway inflammation and injury in children with prevalent weakly acidic gastroesophageal refluxes. Respir Med. 2018; 143:42-47. DOI: 10.1016/j.rmed.2018.08.011. View

2.
Licari A, Castagnoli R, Marseglia A, Olivero F, Votto M, Ciprandi G . Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents. Paediatr Drugs. 2020; 22(3):295-310. DOI: 10.1007/s40272-020-00387-2. View

3.
Rogliani P, Sforza M, Calzetta L . The impact of comorbidities on severe asthma. Curr Opin Pulm Med. 2019; 26(1):47-55. DOI: 10.1097/MCP.0000000000000640. View

4.
Todd S, Walsted E, Grillo L, Livingston R, Menzies-Gow A, Hull J . Novel assessment tool to detect breathing pattern disorder in patients with refractory asthma. Respirology. 2017; 23(3):284-290. DOI: 10.1111/resp.13173. View

5.
Papadopoulos N, Aggelides X, Stamataki S, Prokopakis E, Katotomichelakis M, Xepapadaki P . New concepts in pediatric rhinitis. Pediatr Allergy Immunol. 2021; 32(4):635-646. DOI: 10.1111/pai.13454. View